Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]) Article Swipe
Charles E. Geyer
,
Joanne L. Blum
,
Greg Yothers
,
Lina Asmar
,
Patrick J. Flynn
,
Nicholas J. Robert
,
Judith O. Hopkins
,
Joyce O’Shaughnessy
,
Priya Rastogi
,
Shannon L. Puhalla
,
Christie Hilton
,
Chau T. Dang
,
Henry L. Gómez
,
Svetislava J. Vukelja
,
Alan P. Lyss
,
Devchand Paul
,
Adam Brufsky
,
Linda H. Colangelo
,
Sandra M. Swain
,
Eleftherios P. Mamounas
,
Norman Wolmark
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1200/jco.23.01428
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1200/jco.23.01428
Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to disseminate additional results from studies, published in JCO or elsewhere, for which the primary end point has already been reported. The primary joint efficacy analysis of the Anthracyclines in Early Breast Cancer (ABC) trials reported in 2017 failed to demonstrate nonanthracycline adjuvant therapy was noninferior to anthracycline-based regimens in high-risk, early breast cancer. Full analyses of the studies had proceeded when the prespecified futility boundary was crossed at a planned futility analysis for the ability to demonstrate noninferiority of a nonanthracycline regimen with continued follow-up. These results were presented with 3.3 years of median follow-up. This manuscript reports results of the final analyses of the study efficacy end points conducted with 6.9 years of median follow-up. Long-term analysis of invasive disease-free survival (IDFS), the primary end point of the ABC trials, remains consistent with the original results, as noninferiority of the nonanthracycline regimens could not be declared on the basis of the original criteria. The secondary end point of recurrence-free interval, which excluded deaths not due to breast cancer as events, favored anthracycline-based regimens, and tests for heterogeneity were significant for hormone receptor status ( P = .02) favoring anthracycline regimens for the hormone receptor–negative cohorts. There was no difference in overall survival, and review of the type of IDFS events in the groups suggested reductions in cancer recurrences achieved with anthracycline regimens were offset by late leukemias and deaths unrelated to breast cancer.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1200/jco.23.01428
- OA Status
- green
- Cited By
- 18
- References
- 4
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4391676172
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4391676172Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1200/jco.23.01428Digital Object Identifier
- Title
-
Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology])Work title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-02-09Full publication date if available
- Authors
-
Charles E. Geyer, Joanne L. Blum, Greg Yothers, Lina Asmar, Patrick J. Flynn, Nicholas J. Robert, Judith O. Hopkins, Joyce O’Shaughnessy, Priya Rastogi, Shannon L. Puhalla, Christie Hilton, Chau T. Dang, Henry L. Gómez, Svetislava J. Vukelja, Alan P. Lyss, Devchand Paul, Adam Brufsky, Linda H. Colangelo, Sandra M. Swain, Eleftherios P. Mamounas, Norman WolmarkList of authors in order
- Landing page
-
https://doi.org/10.1200/jco.23.01428Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://www.ncbi.nlm.nih.gov/pmc/articles/11095853Direct OA link when available
- Concepts
-
Medicine, Anthracycline, Oncology, Internal medicine, Breast cancer, Clinical endpoint, Regimen, Clinical trial, CancerTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
18Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 12, 2024: 6Per-year citation counts (last 5 years)
- References (count)
-
4Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4391676172 |
|---|---|
| doi | https://doi.org/10.1200/jco.23.01428 |
| ids.doi | https://doi.org/10.1200/jco.23.01428 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/38335467 |
| ids.openalex | https://openalex.org/W4391676172 |
| fwci | 10.22246555 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D005260 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Female |
| mesh[2].qualifier_ui | Q000627 |
| mesh[2].descriptor_ui | D043823 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | therapeutic use |
| mesh[2].descriptor_name | Taxoids |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D005500 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Follow-Up Studies |
| mesh[4].qualifier_ui | Q000188 |
| mesh[4].descriptor_ui | D001943 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | drug therapy |
| mesh[4].descriptor_name | Breast Neoplasms |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D018943 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Anthracyclines |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D006728 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Hormones |
| mesh[7].qualifier_ui | Q000627 |
| mesh[7].descriptor_ui | D000971 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | therapeutic use |
| mesh[7].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D006801 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Humans |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D005260 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Female |
| mesh[10].qualifier_ui | Q000627 |
| mesh[10].descriptor_ui | D043823 |
| mesh[10].is_major_topic | True |
| mesh[10].qualifier_name | therapeutic use |
| mesh[10].descriptor_name | Taxoids |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D005500 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Follow-Up Studies |
| mesh[12].qualifier_ui | Q000188 |
| mesh[12].descriptor_ui | D001943 |
| mesh[12].is_major_topic | True |
| mesh[12].qualifier_name | drug therapy |
| mesh[12].descriptor_name | Breast Neoplasms |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D018943 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Anthracyclines |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D006728 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Hormones |
| mesh[15].qualifier_ui | Q000627 |
| mesh[15].descriptor_ui | D000971 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | therapeutic use |
| mesh[15].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D006801 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Humans |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D005260 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Female |
| mesh[18].qualifier_ui | Q000627 |
| mesh[18].descriptor_ui | D043823 |
| mesh[18].is_major_topic | True |
| mesh[18].qualifier_name | therapeutic use |
| mesh[18].descriptor_name | Taxoids |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D005500 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Follow-Up Studies |
| mesh[20].qualifier_ui | Q000188 |
| mesh[20].descriptor_ui | D001943 |
| mesh[20].is_major_topic | True |
| mesh[20].qualifier_name | drug therapy |
| mesh[20].descriptor_name | Breast Neoplasms |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D018943 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Anthracyclines |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D006728 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Hormones |
| mesh[23].qualifier_ui | Q000627 |
| mesh[23].descriptor_ui | D000971 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | therapeutic use |
| mesh[23].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[24].qualifier_ui | |
| mesh[24].descriptor_ui | D006801 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | |
| mesh[24].descriptor_name | Humans |
| mesh[25].qualifier_ui | |
| mesh[25].descriptor_ui | D005260 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | |
| mesh[25].descriptor_name | Female |
| mesh[26].qualifier_ui | Q000627 |
| mesh[26].descriptor_ui | D043823 |
| mesh[26].is_major_topic | True |
| mesh[26].qualifier_name | therapeutic use |
| mesh[26].descriptor_name | Taxoids |
| mesh[27].qualifier_ui | |
| mesh[27].descriptor_ui | D005500 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | |
| mesh[27].descriptor_name | Follow-Up Studies |
| mesh[28].qualifier_ui | Q000188 |
| mesh[28].descriptor_ui | D001943 |
| mesh[28].is_major_topic | True |
| mesh[28].qualifier_name | drug therapy |
| mesh[28].descriptor_name | Breast Neoplasms |
| mesh[29].qualifier_ui | |
| mesh[29].descriptor_ui | D018943 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | |
| mesh[29].descriptor_name | Anthracyclines |
| mesh[30].qualifier_ui | |
| mesh[30].descriptor_ui | D006728 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | |
| mesh[30].descriptor_name | Hormones |
| mesh[31].qualifier_ui | Q000627 |
| mesh[31].descriptor_ui | D000971 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | therapeutic use |
| mesh[31].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[32].qualifier_ui | |
| mesh[32].descriptor_ui | D006801 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | |
| mesh[32].descriptor_name | Humans |
| mesh[33].qualifier_ui | |
| mesh[33].descriptor_ui | D005260 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | |
| mesh[33].descriptor_name | Female |
| mesh[34].qualifier_ui | Q000627 |
| mesh[34].descriptor_ui | D043823 |
| mesh[34].is_major_topic | True |
| mesh[34].qualifier_name | therapeutic use |
| mesh[34].descriptor_name | Taxoids |
| mesh[35].qualifier_ui | |
| mesh[35].descriptor_ui | D005500 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | |
| mesh[35].descriptor_name | Follow-Up Studies |
| mesh[36].qualifier_ui | Q000188 |
| mesh[36].descriptor_ui | D001943 |
| mesh[36].is_major_topic | True |
| mesh[36].qualifier_name | drug therapy |
| mesh[36].descriptor_name | Breast Neoplasms |
| mesh[37].qualifier_ui | |
| mesh[37].descriptor_ui | D018943 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | |
| mesh[37].descriptor_name | Anthracyclines |
| mesh[38].qualifier_ui | |
| mesh[38].descriptor_ui | D006728 |
| mesh[38].is_major_topic | False |
| mesh[38].qualifier_name | |
| mesh[38].descriptor_name | Hormones |
| mesh[39].qualifier_ui | Q000627 |
| mesh[39].descriptor_ui | D000971 |
| mesh[39].is_major_topic | False |
| mesh[39].qualifier_name | therapeutic use |
| mesh[39].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[40].qualifier_ui | |
| mesh[40].descriptor_ui | D006801 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | |
| mesh[40].descriptor_name | Humans |
| mesh[41].qualifier_ui | |
| mesh[41].descriptor_ui | D005260 |
| mesh[41].is_major_topic | False |
| mesh[41].qualifier_name | |
| mesh[41].descriptor_name | Female |
| mesh[42].qualifier_ui | Q000627 |
| mesh[42].descriptor_ui | D043823 |
| mesh[42].is_major_topic | True |
| mesh[42].qualifier_name | therapeutic use |
| mesh[42].descriptor_name | Taxoids |
| mesh[43].qualifier_ui | |
| mesh[43].descriptor_ui | D005500 |
| mesh[43].is_major_topic | False |
| mesh[43].qualifier_name | |
| mesh[43].descriptor_name | Follow-Up Studies |
| mesh[44].qualifier_ui | Q000188 |
| mesh[44].descriptor_ui | D001943 |
| mesh[44].is_major_topic | True |
| mesh[44].qualifier_name | drug therapy |
| mesh[44].descriptor_name | Breast Neoplasms |
| mesh[45].qualifier_ui | |
| mesh[45].descriptor_ui | D018943 |
| mesh[45].is_major_topic | False |
| mesh[45].qualifier_name | |
| mesh[45].descriptor_name | Anthracyclines |
| mesh[46].qualifier_ui | |
| mesh[46].descriptor_ui | D006728 |
| mesh[46].is_major_topic | False |
| mesh[46].qualifier_name | |
| mesh[46].descriptor_name | Hormones |
| mesh[47].qualifier_ui | Q000627 |
| mesh[47].descriptor_ui | D000971 |
| mesh[47].is_major_topic | False |
| mesh[47].qualifier_name | therapeutic use |
| mesh[47].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[48].qualifier_ui | |
| mesh[48].descriptor_ui | D006801 |
| mesh[48].is_major_topic | False |
| mesh[48].qualifier_name | |
| mesh[48].descriptor_name | Humans |
| mesh[49].qualifier_ui | |
| mesh[49].descriptor_ui | D005260 |
| mesh[49].is_major_topic | False |
| mesh[49].qualifier_name | |
| mesh[49].descriptor_name | Female |
| type | article |
| title | Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]) |
| biblio.issue | 12 |
| biblio.volume | 42 |
| biblio.last_page | 1349 |
| biblio.first_page | 1344 |
| topics[0].id | https://openalex.org/T10183 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 0.9995999932289124 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1306 |
| topics[0].subfield.display_name | Cancer Research |
| topics[0].display_name | Breast Cancer Treatment Studies |
| topics[1].id | https://openalex.org/T11752 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9990000128746033 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2730 |
| topics[1].subfield.display_name | Oncology |
| topics[1].display_name | Cancer Treatment and Pharmacology |
| topics[2].id | https://openalex.org/T12829 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9983999729156494 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2740 |
| topics[2].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[2].display_name | Advanced Breast Cancer Therapies |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.8521254062652588 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2776802502 |
| concepts[1].level | 4 |
| concepts[1].score | 0.7714540958404541 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q417589 |
| concepts[1].display_name | Anthracycline |
| concepts[2].id | https://openalex.org/C143998085 |
| concepts[2].level | 1 |
| concepts[2].score | 0.6886388063430786 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[2].display_name | Oncology |
| concepts[3].id | https://openalex.org/C126322002 |
| concepts[3].level | 1 |
| concepts[3].score | 0.6775025725364685 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[3].display_name | Internal medicine |
| concepts[4].id | https://openalex.org/C530470458 |
| concepts[4].level | 3 |
| concepts[4].score | 0.6712266802787781 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q128581 |
| concepts[4].display_name | Breast cancer |
| concepts[5].id | https://openalex.org/C203092338 |
| concepts[5].level | 3 |
| concepts[5].score | 0.6016573309898376 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q1340863 |
| concepts[5].display_name | Clinical endpoint |
| concepts[6].id | https://openalex.org/C2781413609 |
| concepts[6].level | 2 |
| concepts[6].score | 0.5275335311889648 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q7308373 |
| concepts[6].display_name | Regimen |
| concepts[7].id | https://openalex.org/C535046627 |
| concepts[7].level | 2 |
| concepts[7].score | 0.521346926689148 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q30612 |
| concepts[7].display_name | Clinical trial |
| concepts[8].id | https://openalex.org/C121608353 |
| concepts[8].level | 2 |
| concepts[8].score | 0.45252081751823425 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[8].display_name | Cancer |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.8521254062652588 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/anthracycline |
| keywords[1].score | 0.7714540958404541 |
| keywords[1].display_name | Anthracycline |
| keywords[2].id | https://openalex.org/keywords/oncology |
| keywords[2].score | 0.6886388063430786 |
| keywords[2].display_name | Oncology |
| keywords[3].id | https://openalex.org/keywords/internal-medicine |
| keywords[3].score | 0.6775025725364685 |
| keywords[3].display_name | Internal medicine |
| keywords[4].id | https://openalex.org/keywords/breast-cancer |
| keywords[4].score | 0.6712266802787781 |
| keywords[4].display_name | Breast cancer |
| keywords[5].id | https://openalex.org/keywords/clinical-endpoint |
| keywords[5].score | 0.6016573309898376 |
| keywords[5].display_name | Clinical endpoint |
| keywords[6].id | https://openalex.org/keywords/regimen |
| keywords[6].score | 0.5275335311889648 |
| keywords[6].display_name | Regimen |
| keywords[7].id | https://openalex.org/keywords/clinical-trial |
| keywords[7].score | 0.521346926689148 |
| keywords[7].display_name | Clinical trial |
| keywords[8].id | https://openalex.org/keywords/cancer |
| keywords[8].score | 0.45252081751823425 |
| keywords[8].display_name | Cancer |
| language | en |
| locations[0].id | doi:10.1200/jco.23.01428 |
| locations[0].is_oa | False |
| locations[0].source.id | https://openalex.org/S15137598 |
| locations[0].source.issn | 0732-183X, 1527-7755 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0732-183X |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Journal of Clinical Oncology |
| locations[0].source.host_organization | https://openalex.org/P4310315671 |
| locations[0].source.host_organization_name | Lippincott Williams & Wilkins |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310315671 |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Journal of Clinical Oncology |
| locations[0].landing_page_url | https://doi.org/10.1200/jco.23.01428 |
| locations[1].id | pmid:38335467 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Journal of clinical oncology : official journal of the American Society of Clinical Oncology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/38335467 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:11095853 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | J Clin Oncol |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11095853 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5063504632 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-2379-5702 |
| authorships[0].author.display_name | Charles E. Geyer |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210162619, https://openalex.org/I4210162844 |
| authorships[0].affiliations[0].raw_affiliation_string | NSABP Foundation/NRG Oncology, Pittsburgh, PA |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I4210128526 |
| authorships[0].affiliations[1].raw_affiliation_string | UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA |
| authorships[0].institutions[0].id | https://openalex.org/I4210162619 |
| authorships[0].institutions[0].ror | https://ror.org/050draa26 |
| authorships[0].institutions[0].type | nonprofit |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210162619 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | NRG Oncology |
| authorships[0].institutions[1].id | https://openalex.org/I4210162844 |
| authorships[0].institutions[1].ror | https://ror.org/05e2f9085 |
| authorships[0].institutions[1].type | nonprofit |
| authorships[0].institutions[1].lineage | https://openalex.org/I4210162844 |
| authorships[0].institutions[1].country_code | US |
| authorships[0].institutions[1].display_name | NSABP Foundation |
| authorships[0].institutions[2].id | https://openalex.org/I4210128526 |
| authorships[0].institutions[2].ror | https://ror.org/03bw34a45 |
| authorships[0].institutions[2].type | facility |
| authorships[0].institutions[2].lineage | https://openalex.org/I170201317, https://openalex.org/I4210128526 |
| authorships[0].institutions[2].country_code | US |
| authorships[0].institutions[2].display_name | UPMC Hillman Cancer Center |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Charles E. Geyer |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | NSABP Foundation/NRG Oncology, Pittsburgh, PA, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA |
| authorships[1].author.id | https://openalex.org/A5042123072 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-7951-6645 |
| authorships[1].author.display_name | Joanne L. Blum |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I2800124591 |
| authorships[1].affiliations[0].raw_affiliation_string | Baylor-Sammons Cancer Center, Texas Oncology, US Oncology Research, Dallas, TX |
| authorships[1].institutions[0].id | https://openalex.org/I2800124591 |
| authorships[1].institutions[0].ror | https://ror.org/02ketev28 |
| authorships[1].institutions[0].type | facility |
| authorships[1].institutions[0].lineage | https://openalex.org/I2800124591 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | Texas Oncology |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Joanne L. Blum |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Baylor-Sammons Cancer Center, Texas Oncology, US Oncology Research, Dallas, TX |
| authorships[2].author.id | https://openalex.org/A5057918523 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-7965-7333 |
| authorships[2].author.display_name | Greg Yothers |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I170201317, https://openalex.org/I4210162619 |
| authorships[2].affiliations[0].raw_affiliation_string | NRG Oncology SDMC, Department of Biostatistics, and University of Pittsburgh School of Public Health, Pittsburgh, PA |
| authorships[2].institutions[0].id | https://openalex.org/I4210162619 |
| authorships[2].institutions[0].ror | https://ror.org/050draa26 |
| authorships[2].institutions[0].type | nonprofit |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210162619 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | NRG Oncology |
| authorships[2].institutions[1].id | https://openalex.org/I170201317 |
| authorships[2].institutions[1].ror | https://ror.org/01an3r305 |
| authorships[2].institutions[1].type | education |
| authorships[2].institutions[1].lineage | https://openalex.org/I170201317 |
| authorships[2].institutions[1].country_code | US |
| authorships[2].institutions[1].display_name | University of Pittsburgh |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Greg Yothers |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | NRG Oncology SDMC, Department of Biostatistics, and University of Pittsburgh School of Public Health, Pittsburgh, PA |
| authorships[3].author.id | https://openalex.org/A5028916394 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Lina Asmar |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I1318987563 |
| authorships[3].affiliations[0].raw_affiliation_string | USOR, McKesson Specialty Health, The Woodlands, TX |
| authorships[3].institutions[0].id | https://openalex.org/I1318987563 |
| authorships[3].institutions[0].ror | https://ror.org/057r09725 |
| authorships[3].institutions[0].type | company |
| authorships[3].institutions[0].lineage | https://openalex.org/I1318987563 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | McKesson (United States) |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Lina Asmar |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | USOR, McKesson Specialty Health, The Woodlands, TX |
| authorships[4].author.id | https://openalex.org/A5012465182 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-6516-8021 |
| authorships[4].author.display_name | Patrick J. Flynn |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210120135 |
| authorships[4].affiliations[0].raw_affiliation_string | Minnesota Community Oncology Research Consortium (MSORC), Stone Lake, MI |
| authorships[4].institutions[0].id | https://openalex.org/I4210120135 |
| authorships[4].institutions[0].ror | https://ror.org/02vhx9606 |
| authorships[4].institutions[0].type | nonprofit |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210120135 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | Metro-Minnesota Community Oncology Research Consortium |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Patrick J. Flynn |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Minnesota Community Oncology Research Consortium (MSORC), Stone Lake, MI |
| authorships[5].author.id | https://openalex.org/A5075481530 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-8491-5392 |
| authorships[5].author.display_name | Nicholas J. Robert |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I143032186 |
| authorships[5].affiliations[0].raw_affiliation_string | Ontada, Irving, TX |
| authorships[5].institutions[0].id | https://openalex.org/I143032186 |
| authorships[5].institutions[0].ror | https://ror.org/02jqp5961 |
| authorships[5].institutions[0].type | company |
| authorships[5].institutions[0].lineage | https://openalex.org/I143032186 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | Reata Pharmaceuticals (United States) |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Nicholas J. Robert |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Ontada, Irving, TX |
| authorships[6].author.id | https://openalex.org/A5044446652 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-9829-1242 |
| authorships[6].author.display_name | Judith O. Hopkins |
| authorships[6].countries | US |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I2802152183 |
| authorships[6].affiliations[0].raw_affiliation_string | Novant Health (Forsyth Medical) Cancer Institute, Southeast Clinical Oncology Research (SCOR) NCORP, Winston Salem, NC |
| authorships[6].institutions[0].id | https://openalex.org/I2802152183 |
| authorships[6].institutions[0].ror | https://ror.org/04nv2wh79 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I2802152183 |
| authorships[6].institutions[0].country_code | US |
| authorships[6].institutions[0].display_name | Novant Health |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Judith O. Hopkins |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Novant Health (Forsyth Medical) Cancer Institute, Southeast Clinical Oncology Research (SCOR) NCORP, Winston Salem, NC |
| authorships[7].author.id | https://openalex.org/A5071432873 |
| authorships[7].author.orcid | https://orcid.org/0000-0001-6764-2807 |
| authorships[7].author.display_name | Joyce O’Shaughnessy |
| authorships[7].countries | US |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I2800124591, https://openalex.org/I2802366037 |
| authorships[7].affiliations[0].raw_affiliation_string | Baylor University Medical Center, Texas Oncology, US Oncology Research, Dallas, TX |
| authorships[7].institutions[0].id | https://openalex.org/I2802366037 |
| authorships[7].institutions[0].ror | https://ror.org/03nxfhe13 |
| authorships[7].institutions[0].type | healthcare |
| authorships[7].institutions[0].lineage | https://openalex.org/I2802366037, https://openalex.org/I4210160418 |
| authorships[7].institutions[0].country_code | US |
| authorships[7].institutions[0].display_name | Baylor University Medical Center |
| authorships[7].institutions[1].id | https://openalex.org/I2800124591 |
| authorships[7].institutions[1].ror | https://ror.org/02ketev28 |
| authorships[7].institutions[1].type | facility |
| authorships[7].institutions[1].lineage | https://openalex.org/I2800124591 |
| authorships[7].institutions[1].country_code | US |
| authorships[7].institutions[1].display_name | Texas Oncology |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Joyce A. O'Shaughnessy |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Baylor University Medical Center, Texas Oncology, US Oncology Research, Dallas, TX |
| authorships[8].author.id | https://openalex.org/A5002068827 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-6179-6407 |
| authorships[8].author.display_name | Priya Rastogi |
| authorships[8].countries | US |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210128526 |
| authorships[8].affiliations[0].raw_affiliation_string | UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA |
| authorships[8].affiliations[1].institution_ids | https://openalex.org/I4210162619, https://openalex.org/I4210162844 |
| authorships[8].affiliations[1].raw_affiliation_string | NSABP Foundation/NRG Oncology, Pittsburgh, PA |
| authorships[8].affiliations[2].institution_ids | https://openalex.org/I4210106153 |
| authorships[8].affiliations[2].raw_affiliation_string | UPMC Magee-Womens Hospital, Pittsburgh, PA |
| authorships[8].institutions[0].id | https://openalex.org/I4210106153 |
| authorships[8].institutions[0].ror | https://ror.org/01fbdn283 |
| authorships[8].institutions[0].type | healthcare |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210098814, https://openalex.org/I4210106153, https://openalex.org/I4210134769 |
| authorships[8].institutions[0].country_code | US |
| authorships[8].institutions[0].display_name | Magee-Womens Hospital |
| authorships[8].institutions[1].id | https://openalex.org/I4210162619 |
| authorships[8].institutions[1].ror | https://ror.org/050draa26 |
| authorships[8].institutions[1].type | nonprofit |
| authorships[8].institutions[1].lineage | https://openalex.org/I4210162619 |
| authorships[8].institutions[1].country_code | US |
| authorships[8].institutions[1].display_name | NRG Oncology |
| authorships[8].institutions[2].id | https://openalex.org/I4210162844 |
| authorships[8].institutions[2].ror | https://ror.org/05e2f9085 |
| authorships[8].institutions[2].type | nonprofit |
| authorships[8].institutions[2].lineage | https://openalex.org/I4210162844 |
| authorships[8].institutions[2].country_code | US |
| authorships[8].institutions[2].display_name | NSABP Foundation |
| authorships[8].institutions[3].id | https://openalex.org/I4210128526 |
| authorships[8].institutions[3].ror | https://ror.org/03bw34a45 |
| authorships[8].institutions[3].type | facility |
| authorships[8].institutions[3].lineage | https://openalex.org/I170201317, https://openalex.org/I4210128526 |
| authorships[8].institutions[3].country_code | US |
| authorships[8].institutions[3].display_name | UPMC Hillman Cancer Center |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Priya Rastogi |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | NSABP Foundation/NRG Oncology, Pittsburgh, PA, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA, UPMC Magee-Womens Hospital, Pittsburgh, PA |
| authorships[9].author.id | https://openalex.org/A5105938107 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | Shannon L. Puhalla |
| authorships[9].countries | US |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I4210162619, https://openalex.org/I4210162844 |
| authorships[9].affiliations[0].raw_affiliation_string | NSABP Foundation/NRG Oncology, Pittsburgh, PA |
| authorships[9].affiliations[1].institution_ids | https://openalex.org/I4210128526 |
| authorships[9].affiliations[1].raw_affiliation_string | UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA |
| authorships[9].institutions[0].id | https://openalex.org/I4210162619 |
| authorships[9].institutions[0].ror | https://ror.org/050draa26 |
| authorships[9].institutions[0].type | nonprofit |
| authorships[9].institutions[0].lineage | https://openalex.org/I4210162619 |
| authorships[9].institutions[0].country_code | US |
| authorships[9].institutions[0].display_name | NRG Oncology |
| authorships[9].institutions[1].id | https://openalex.org/I4210162844 |
| authorships[9].institutions[1].ror | https://ror.org/05e2f9085 |
| authorships[9].institutions[1].type | nonprofit |
| authorships[9].institutions[1].lineage | https://openalex.org/I4210162844 |
| authorships[9].institutions[1].country_code | US |
| authorships[9].institutions[1].display_name | NSABP Foundation |
| authorships[9].institutions[2].id | https://openalex.org/I4210128526 |
| authorships[9].institutions[2].ror | https://ror.org/03bw34a45 |
| authorships[9].institutions[2].type | facility |
| authorships[9].institutions[2].lineage | https://openalex.org/I170201317, https://openalex.org/I4210128526 |
| authorships[9].institutions[2].country_code | US |
| authorships[9].institutions[2].display_name | UPMC Hillman Cancer Center |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Shannon L. Puhalla |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | NSABP Foundation/NRG Oncology, Pittsburgh, PA, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA |
| authorships[10].author.id | https://openalex.org/A5108523072 |
| authorships[10].author.orcid | |
| authorships[10].author.display_name | Christie Hilton |
| authorships[10].countries | US |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I4210162619, https://openalex.org/I4210162844 |
| authorships[10].affiliations[0].raw_affiliation_string | NSABP Foundation/NRG Oncology, Pittsburgh, PA |
| authorships[10].affiliations[1].institution_ids | https://openalex.org/I1310421338 |
| authorships[10].affiliations[1].raw_affiliation_string | Allegheny Health Network, Pittsburgh, PA |
| authorships[10].institutions[0].id | https://openalex.org/I1310421338 |
| authorships[10].institutions[0].ror | https://ror.org/0101kry21 |
| authorships[10].institutions[0].type | healthcare |
| authorships[10].institutions[0].lineage | https://openalex.org/I1310421338 |
| authorships[10].institutions[0].country_code | US |
| authorships[10].institutions[0].display_name | Allegheny Health Network |
| authorships[10].institutions[1].id | https://openalex.org/I4210162619 |
| authorships[10].institutions[1].ror | https://ror.org/050draa26 |
| authorships[10].institutions[1].type | nonprofit |
| authorships[10].institutions[1].lineage | https://openalex.org/I4210162619 |
| authorships[10].institutions[1].country_code | US |
| authorships[10].institutions[1].display_name | NRG Oncology |
| authorships[10].institutions[2].id | https://openalex.org/I4210162844 |
| authorships[10].institutions[2].ror | https://ror.org/05e2f9085 |
| authorships[10].institutions[2].type | nonprofit |
| authorships[10].institutions[2].lineage | https://openalex.org/I4210162844 |
| authorships[10].institutions[2].country_code | US |
| authorships[10].institutions[2].display_name | NSABP Foundation |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Christie J. Hilton |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Allegheny Health Network, Pittsburgh, PA, NSABP Foundation/NRG Oncology, Pittsburgh, PA |
| authorships[11].author.id | https://openalex.org/A5068207600 |
| authorships[11].author.orcid | https://orcid.org/0000-0001-5133-2265 |
| authorships[11].author.display_name | Chau T. Dang |
| authorships[11].countries | US |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I1334819555 |
| authorships[11].affiliations[0].raw_affiliation_string | Memorial Sloan Kettering Cancer Center, West Harrison, NY |
| authorships[11].institutions[0].id | https://openalex.org/I1334819555 |
| authorships[11].institutions[0].ror | https://ror.org/02yrq0923 |
| authorships[11].institutions[0].type | healthcare |
| authorships[11].institutions[0].lineage | https://openalex.org/I1334819555 |
| authorships[11].institutions[0].country_code | US |
| authorships[11].institutions[0].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Chau T. Dang |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Memorial Sloan Kettering Cancer Center, West Harrison, NY |
| authorships[12].author.id | https://openalex.org/A5113115918 |
| authorships[12].author.orcid | |
| authorships[12].author.display_name | Henry L. Gómez |
| authorships[12].countries | PE |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I4210123325 |
| authorships[12].affiliations[0].raw_affiliation_string | National Institute of Neoplastic Diseases, Lima, Peru |
| authorships[12].institutions[0].id | https://openalex.org/I4210123325 |
| authorships[12].institutions[0].ror | https://ror.org/03674y156 |
| authorships[12].institutions[0].type | healthcare |
| authorships[12].institutions[0].lineage | https://openalex.org/I4210123325 |
| authorships[12].institutions[0].country_code | PE |
| authorships[12].institutions[0].display_name | Instituto Nacional de Enfermedades Neoplásicas |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Henry Leonidas Gómez |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | National Institute of Neoplastic Diseases, Lima, Peru |
| authorships[13].author.id | https://openalex.org/A5008682252 |
| authorships[13].author.orcid | |
| authorships[13].author.display_name | Svetislava J. Vukelja |
| authorships[13].affiliations[0].raw_affiliation_string | US Oncology Tyler Cancer Center, Tyler, TX |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Svetislava J. Vukelja |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | US Oncology Tyler Cancer Center, Tyler, TX |
| authorships[14].author.id | https://openalex.org/A5077437003 |
| authorships[14].author.orcid | |
| authorships[14].author.display_name | Alan P. Lyss |
| authorships[14].countries | US |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I2802222712, https://openalex.org/I4210118753 |
| authorships[14].affiliations[0].raw_affiliation_string | Heartland Cancer Research NCORP-Missouri Baptist Medical Center, St Louis, MO |
| authorships[14].institutions[0].id | https://openalex.org/I4210118753 |
| authorships[14].institutions[0].ror | https://ror.org/03fg03m71 |
| authorships[14].institutions[0].type | healthcare |
| authorships[14].institutions[0].lineage | https://openalex.org/I4210118753 |
| authorships[14].institutions[0].country_code | US |
| authorships[14].institutions[0].display_name | Heartland Cancer Research |
| authorships[14].institutions[1].id | https://openalex.org/I2802222712 |
| authorships[14].institutions[1].ror | https://ror.org/0067dx910 |
| authorships[14].institutions[1].type | healthcare |
| authorships[14].institutions[1].lineage | https://openalex.org/I1328499231, https://openalex.org/I2802222712 |
| authorships[14].institutions[1].country_code | US |
| authorships[14].institutions[1].display_name | Missouri Baptist Medical Center |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Alan P. Lyss |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Heartland Cancer Research NCORP-Missouri Baptist Medical Center, St Louis, MO |
| authorships[15].author.id | https://openalex.org/A5015942645 |
| authorships[15].author.orcid | |
| authorships[15].author.display_name | Devchand Paul |
| authorships[15].countries | US |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I1318987563 |
| authorships[15].affiliations[0].raw_affiliation_string | USOR, McKesson Specialty Health, The Woodlands, TX |
| authorships[15].institutions[0].id | https://openalex.org/I1318987563 |
| authorships[15].institutions[0].ror | https://ror.org/057r09725 |
| authorships[15].institutions[0].type | company |
| authorships[15].institutions[0].lineage | https://openalex.org/I1318987563 |
| authorships[15].institutions[0].country_code | US |
| authorships[15].institutions[0].display_name | McKesson (United States) |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Devchand Paul |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | USOR, McKesson Specialty Health, The Woodlands, TX |
| authorships[16].author.id | https://openalex.org/A5044108002 |
| authorships[16].author.orcid | https://orcid.org/0000-0001-8080-7960 |
| authorships[16].author.display_name | Adam Brufsky |
| authorships[16].countries | US |
| authorships[16].affiliations[0].institution_ids | https://openalex.org/I4210128526 |
| authorships[16].affiliations[0].raw_affiliation_string | UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA |
| authorships[16].affiliations[1].institution_ids | https://openalex.org/I4210106153 |
| authorships[16].affiliations[1].raw_affiliation_string | UPMC Magee-Womens Hospital, Pittsburgh, PA |
| authorships[16].institutions[0].id | https://openalex.org/I4210106153 |
| authorships[16].institutions[0].ror | https://ror.org/01fbdn283 |
| authorships[16].institutions[0].type | healthcare |
| authorships[16].institutions[0].lineage | https://openalex.org/I4210098814, https://openalex.org/I4210106153, https://openalex.org/I4210134769 |
| authorships[16].institutions[0].country_code | US |
| authorships[16].institutions[0].display_name | Magee-Womens Hospital |
| authorships[16].institutions[1].id | https://openalex.org/I4210128526 |
| authorships[16].institutions[1].ror | https://ror.org/03bw34a45 |
| authorships[16].institutions[1].type | facility |
| authorships[16].institutions[1].lineage | https://openalex.org/I170201317, https://openalex.org/I4210128526 |
| authorships[16].institutions[1].country_code | US |
| authorships[16].institutions[1].display_name | UPMC Hillman Cancer Center |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Adam M. Brufsky |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA, UPMC Magee-Womens Hospital, Pittsburgh, PA |
| authorships[17].author.id | https://openalex.org/A5047355804 |
| authorships[17].author.orcid | |
| authorships[17].author.display_name | Linda H. Colangelo |
| authorships[17].countries | US |
| authorships[17].affiliations[0].institution_ids | https://openalex.org/I170201317, https://openalex.org/I4210162619 |
| authorships[17].affiliations[0].raw_affiliation_string | NRG Oncology SDMC, Department of Biostatistics, and University of Pittsburgh School of Public Health, Pittsburgh, PA |
| authorships[17].institutions[0].id | https://openalex.org/I4210162619 |
| authorships[17].institutions[0].ror | https://ror.org/050draa26 |
| authorships[17].institutions[0].type | nonprofit |
| authorships[17].institutions[0].lineage | https://openalex.org/I4210162619 |
| authorships[17].institutions[0].country_code | US |
| authorships[17].institutions[0].display_name | NRG Oncology |
| authorships[17].institutions[1].id | https://openalex.org/I170201317 |
| authorships[17].institutions[1].ror | https://ror.org/01an3r305 |
| authorships[17].institutions[1].type | education |
| authorships[17].institutions[1].lineage | https://openalex.org/I170201317 |
| authorships[17].institutions[1].country_code | US |
| authorships[17].institutions[1].display_name | University of Pittsburgh |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Linda H. Colangelo |
| authorships[17].is_corresponding | False |
| authorships[17].raw_affiliation_strings | NRG Oncology SDMC, Department of Biostatistics, and University of Pittsburgh School of Public Health, Pittsburgh, PA |
| authorships[18].author.id | https://openalex.org/A5067203408 |
| authorships[18].author.orcid | https://orcid.org/0000-0002-1320-3830 |
| authorships[18].author.display_name | Sandra M. Swain |
| authorships[18].countries | US |
| authorships[18].affiliations[0].institution_ids | https://openalex.org/I184565670, https://openalex.org/I2799903593, https://openalex.org/I86755215 |
| authorships[18].affiliations[0].raw_affiliation_string | Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, MedStar Health, Washington, DC |
| authorships[18].affiliations[1].institution_ids | https://openalex.org/I4210162619, https://openalex.org/I4210162844 |
| authorships[18].affiliations[1].raw_affiliation_string | NSABP Foundation/NRG Oncology, Pittsburgh, PA |
| authorships[18].institutions[0].id | https://openalex.org/I184565670 |
| authorships[18].institutions[0].ror | https://ror.org/05vzafd60 |
| authorships[18].institutions[0].type | education |
| authorships[18].institutions[0].lineage | https://openalex.org/I184565670 |
| authorships[18].institutions[0].country_code | US |
| authorships[18].institutions[0].display_name | Georgetown University |
| authorships[18].institutions[1].id | https://openalex.org/I2799903593 |
| authorships[18].institutions[1].ror | https://ror.org/00hjz7x27 |
| authorships[18].institutions[1].type | healthcare |
| authorships[18].institutions[1].lineage | https://openalex.org/I2799903593 |
| authorships[18].institutions[1].country_code | US |
| authorships[18].institutions[1].display_name | Georgetown University Medical Center |
| authorships[18].institutions[2].id | https://openalex.org/I86755215 |
| authorships[18].institutions[2].ror | https://ror.org/05atemp08 |
| authorships[18].institutions[2].type | healthcare |
| authorships[18].institutions[2].lineage | https://openalex.org/I86755215 |
| authorships[18].institutions[2].country_code | US |
| authorships[18].institutions[2].display_name | MedStar Health |
| authorships[18].institutions[3].id | https://openalex.org/I4210162619 |
| authorships[18].institutions[3].ror | https://ror.org/050draa26 |
| authorships[18].institutions[3].type | nonprofit |
| authorships[18].institutions[3].lineage | https://openalex.org/I4210162619 |
| authorships[18].institutions[3].country_code | US |
| authorships[18].institutions[3].display_name | NRG Oncology |
| authorships[18].institutions[4].id | https://openalex.org/I4210162844 |
| authorships[18].institutions[4].ror | https://ror.org/05e2f9085 |
| authorships[18].institutions[4].type | nonprofit |
| authorships[18].institutions[4].lineage | https://openalex.org/I4210162844 |
| authorships[18].institutions[4].country_code | US |
| authorships[18].institutions[4].display_name | NSABP Foundation |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Sandra M. Swain |
| authorships[18].is_corresponding | False |
| authorships[18].raw_affiliation_strings | Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, MedStar Health, Washington, DC, NSABP Foundation/NRG Oncology, Pittsburgh, PA |
| authorships[19].author.id | https://openalex.org/A5082509731 |
| authorships[19].author.orcid | https://orcid.org/0000-0002-9476-2553 |
| authorships[19].author.display_name | Eleftherios P. Mamounas |
| authorships[19].countries | US |
| authorships[19].affiliations[0].institution_ids | https://openalex.org/I147878501 |
| authorships[19].affiliations[0].raw_affiliation_string | Orlando Health Cancer Institute, Orlando, FL |
| authorships[19].affiliations[1].institution_ids | https://openalex.org/I4210162619, https://openalex.org/I4210162844 |
| authorships[19].affiliations[1].raw_affiliation_string | NSABP Foundation/NRG Oncology, Pittsburgh, PA |
| authorships[19].institutions[0].id | https://openalex.org/I4210162619 |
| authorships[19].institutions[0].ror | https://ror.org/050draa26 |
| authorships[19].institutions[0].type | nonprofit |
| authorships[19].institutions[0].lineage | https://openalex.org/I4210162619 |
| authorships[19].institutions[0].country_code | US |
| authorships[19].institutions[0].display_name | NRG Oncology |
| authorships[19].institutions[1].id | https://openalex.org/I4210162844 |
| authorships[19].institutions[1].ror | https://ror.org/05e2f9085 |
| authorships[19].institutions[1].type | nonprofit |
| authorships[19].institutions[1].lineage | https://openalex.org/I4210162844 |
| authorships[19].institutions[1].country_code | US |
| authorships[19].institutions[1].display_name | NSABP Foundation |
| authorships[19].institutions[2].id | https://openalex.org/I147878501 |
| authorships[19].institutions[2].ror | https://ror.org/0488cct49 |
| authorships[19].institutions[2].type | healthcare |
| authorships[19].institutions[2].lineage | https://openalex.org/I147878501 |
| authorships[19].institutions[2].country_code | US |
| authorships[19].institutions[2].display_name | Orlando Health |
| authorships[19].author_position | middle |
| authorships[19].raw_author_name | Eleftherios P. Mamounas |
| authorships[19].is_corresponding | False |
| authorships[19].raw_affiliation_strings | NSABP Foundation/NRG Oncology, Pittsburgh, PA, Orlando Health Cancer Institute, Orlando, FL |
| authorships[20].author.id | https://openalex.org/A5055013606 |
| authorships[20].author.orcid | https://orcid.org/0000-0001-7156-1110 |
| authorships[20].author.display_name | Norman Wolmark |
| authorships[20].countries | US |
| authorships[20].affiliations[0].institution_ids | https://openalex.org/I4210128526 |
| authorships[20].affiliations[0].raw_affiliation_string | UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA |
| authorships[20].affiliations[1].institution_ids | https://openalex.org/I4210162619, https://openalex.org/I4210162844 |
| authorships[20].affiliations[1].raw_affiliation_string | NSABP Foundation/NRG Oncology, Pittsburgh, PA |
| authorships[20].institutions[0].id | https://openalex.org/I4210162619 |
| authorships[20].institutions[0].ror | https://ror.org/050draa26 |
| authorships[20].institutions[0].type | nonprofit |
| authorships[20].institutions[0].lineage | https://openalex.org/I4210162619 |
| authorships[20].institutions[0].country_code | US |
| authorships[20].institutions[0].display_name | NRG Oncology |
| authorships[20].institutions[1].id | https://openalex.org/I4210162844 |
| authorships[20].institutions[1].ror | https://ror.org/05e2f9085 |
| authorships[20].institutions[1].type | nonprofit |
| authorships[20].institutions[1].lineage | https://openalex.org/I4210162844 |
| authorships[20].institutions[1].country_code | US |
| authorships[20].institutions[1].display_name | NSABP Foundation |
| authorships[20].institutions[2].id | https://openalex.org/I4210128526 |
| authorships[20].institutions[2].ror | https://ror.org/03bw34a45 |
| authorships[20].institutions[2].type | facility |
| authorships[20].institutions[2].lineage | https://openalex.org/I170201317, https://openalex.org/I4210128526 |
| authorships[20].institutions[2].country_code | US |
| authorships[20].institutions[2].display_name | UPMC Hillman Cancer Center |
| authorships[20].author_position | last |
| authorships[20].raw_author_name | Norman Wolmark |
| authorships[20].is_corresponding | False |
| authorships[20].raw_affiliation_strings | NSABP Foundation/NRG Oncology, Pittsburgh, PA, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11095853 |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]) |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10183 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 0.9995999932289124 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1306 |
| primary_topic.subfield.display_name | Cancer Research |
| primary_topic.display_name | Breast Cancer Treatment Studies |
| related_works | https://openalex.org/W4391375266, https://openalex.org/W2564270006, https://openalex.org/W2359199352, https://openalex.org/W2142058321, https://openalex.org/W2077857858, https://openalex.org/W4379339737, https://openalex.org/W2000019916, https://openalex.org/W2761538572, https://openalex.org/W2152970784, https://openalex.org/W2750641380 |
| cited_by_count | 18 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 12 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 6 |
| locations_count | 3 |
| best_oa_location.id | pmh:oai:pubmedcentral.nih.gov:11095853 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2764455111 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | PubMed Central |
| best_oa_location.source.host_organization | https://openalex.org/I1299303238 |
| best_oa_location.source.host_organization_name | National Institutes of Health |
| best_oa_location.source.host_organization_lineage | https://openalex.org/I1299303238 |
| best_oa_location.license | |
| best_oa_location.pdf_url | |
| best_oa_location.version | submittedVersion |
| best_oa_location.raw_type | Text |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | False |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | J Clin Oncol |
| best_oa_location.landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11095853 |
| primary_location.id | doi:10.1200/jco.23.01428 |
| primary_location.is_oa | False |
| primary_location.source.id | https://openalex.org/S15137598 |
| primary_location.source.issn | 0732-183X, 1527-7755 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0732-183X |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Journal of Clinical Oncology |
| primary_location.source.host_organization | https://openalex.org/P4310315671 |
| primary_location.source.host_organization_name | Lippincott Williams & Wilkins |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310315671 |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Journal of Clinical Oncology |
| primary_location.landing_page_url | https://doi.org/10.1200/jco.23.01428 |
| publication_date | 2024-02-09 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W2606920283, https://openalex.org/W4293241248, https://openalex.org/W2076983043, https://openalex.org/W4365998047 |
| referenced_works_count | 4 |
| abstract_inverted_index.( | 227 |
| abstract_inverted_index.= | 229 |
| abstract_inverted_index.P | 228 |
| abstract_inverted_index.a | 111, 122 |
| abstract_inverted_index.an | 40 |
| abstract_inverted_index.as | 180, 212 |
| abstract_inverted_index.at | 9, 110 |
| abstract_inverted_index.be | 23, 188 |
| abstract_inverted_index.by | 268 |
| abstract_inverted_index.in | 49, 71, 78, 91, 243, 254, 259 |
| abstract_inverted_index.no | 241 |
| abstract_inverted_index.of | 68, 98, 121, 135, 142, 146, 156, 161, 170, 182, 193, 201, 248, 251 |
| abstract_inverted_index.on | 17, 190 |
| abstract_inverted_index.or | 29, 51 |
| abstract_inverted_index.to | 42, 81, 88, 118, 209, 274 |
| abstract_inverted_index.3.3 | 133 |
| abstract_inverted_index.6.9 | 154 |
| abstract_inverted_index.ABC | 172 |
| abstract_inverted_index.JCO | 50 |
| abstract_inverted_index.The | 12, 63, 197 |
| abstract_inverted_index.and | 217, 246, 271 |
| abstract_inverted_index.are | 32 |
| abstract_inverted_index.due | 208 |
| abstract_inverted_index.end | 5, 20, 57, 150, 168, 199 |
| abstract_inverted_index.for | 53, 115, 219, 223, 234 |
| abstract_inverted_index.had | 101 |
| abstract_inverted_index.has | 59 |
| abstract_inverted_index.key | 26 |
| abstract_inverted_index.may | 22 |
| abstract_inverted_index.not | 33, 187, 207 |
| abstract_inverted_index.the | 18, 55, 69, 99, 104, 116, 143, 147, 166, 171, 177, 183, 191, 194, 235, 249, 255 |
| abstract_inverted_index.was | 86, 108, 240 |
| abstract_inverted_index.yet | 34 |
| abstract_inverted_index..02) | 230 |
| abstract_inverted_index.2017 | 79 |
| abstract_inverted_index.Full | 96 |
| abstract_inverted_index.IDFS | 252 |
| abstract_inverted_index.This | 138 |
| abstract_inverted_index.been | 61 |
| abstract_inverted_index.from | 46 |
| abstract_inverted_index.late | 269 |
| abstract_inverted_index.that | 7 |
| abstract_inverted_index.type | 250 |
| abstract_inverted_index.were | 130, 221, 266 |
| abstract_inverted_index.when | 25, 103 |
| abstract_inverted_index.with | 125, 132, 153, 176, 263 |
| abstract_inverted_index.(ABC) | 75 |
| abstract_inverted_index.Early | 72 |
| abstract_inverted_index.There | 239 |
| abstract_inverted_index.These | 128 |
| abstract_inverted_index.Trial | 37 |
| abstract_inverted_index.based | 16 |
| abstract_inverted_index.basis | 192 |
| abstract_inverted_index.could | 186 |
| abstract_inverted_index.early | 93 |
| abstract_inverted_index.final | 144 |
| abstract_inverted_index.joint | 65 |
| abstract_inverted_index.point | 58, 169, 200 |
| abstract_inverted_index.study | 148 |
| abstract_inverted_index.tests | 218 |
| abstract_inverted_index.which | 54, 204 |
| abstract_inverted_index.years | 134, 155 |
| abstract_inverted_index.Breast | 73 |
| abstract_inverted_index.Cancer | 74 |
| abstract_inverted_index.breast | 94, 210, 275 |
| abstract_inverted_index.cancer | 211, 260 |
| abstract_inverted_index.deaths | 206, 272 |
| abstract_inverted_index.events | 253 |
| abstract_inverted_index.failed | 80 |
| abstract_inverted_index.groups | 256 |
| abstract_inverted_index.mature | 8 |
| abstract_inverted_index.median | 136, 157 |
| abstract_inverted_index.offset | 267 |
| abstract_inverted_index.point, | 21 |
| abstract_inverted_index.points | 6, 151 |
| abstract_inverted_index.review | 247 |
| abstract_inverted_index.status | 226 |
| abstract_inverted_index.times. | 11 |
| abstract_inverted_index.trials | 1, 76 |
| abstract_inverted_index.(IDFS), | 165 |
| abstract_inverted_index.Updates | 38 |
| abstract_inverted_index.ability | 117 |
| abstract_inverted_index.already | 60 |
| abstract_inverted_index.cancer. | 95, 276 |
| abstract_inverted_index.crossed | 109 |
| abstract_inverted_index.events, | 213 |
| abstract_inverted_index.favored | 214 |
| abstract_inverted_index.hormone | 224, 236 |
| abstract_inverted_index.include | 3 |
| abstract_inverted_index.initial | 13 |
| abstract_inverted_index.overall | 244 |
| abstract_inverted_index.planned | 27, 112 |
| abstract_inverted_index.primary | 19, 56, 64, 167 |
| abstract_inverted_index.provide | 39 |
| abstract_inverted_index.regimen | 124 |
| abstract_inverted_index.remains | 174 |
| abstract_inverted_index.report, | 14 |
| abstract_inverted_index.reports | 140 |
| abstract_inverted_index.results | 45, 129, 141 |
| abstract_inverted_index.studies | 100 |
| abstract_inverted_index.therapy | 85 |
| abstract_inverted_index.trials, | 173 |
| abstract_inverted_index.Clinical | 0, 36 |
| abstract_inverted_index.achieved | 262 |
| abstract_inverted_index.adjuvant | 84 |
| abstract_inverted_index.analyses | 31, 97, 145 |
| abstract_inverted_index.analysis | 67, 114, 160 |
| abstract_inverted_index.boundary | 107 |
| abstract_inverted_index.cohorts. | 238 |
| abstract_inverted_index.declared | 189 |
| abstract_inverted_index.efficacy | 66, 149 |
| abstract_inverted_index.excluded | 205 |
| abstract_inverted_index.favoring | 231 |
| abstract_inverted_index.futility | 106, 113 |
| abstract_inverted_index.invasive | 162 |
| abstract_inverted_index.multiple | 4 |
| abstract_inverted_index.original | 178, 195 |
| abstract_inverted_index.receptor | 225 |
| abstract_inverted_index.regimens | 90, 185, 233, 265 |
| abstract_inverted_index.reported | 77 |
| abstract_inverted_index.results, | 179 |
| abstract_inverted_index.studies, | 47 |
| abstract_inverted_index.survival | 164 |
| abstract_inverted_index.Long-term | 159 |
| abstract_inverted_index.conducted | 152 |
| abstract_inverted_index.continued | 126 |
| abstract_inverted_index.criteria. | 196 |
| abstract_inverted_index.different | 10 |
| abstract_inverted_index.interval, | 203 |
| abstract_inverted_index.leukemias | 270 |
| abstract_inverted_index.presented | 131 |
| abstract_inverted_index.proceeded | 102 |
| abstract_inverted_index.published | 24, 48 |
| abstract_inverted_index.regimens, | 216 |
| abstract_inverted_index.reported. | 62 |
| abstract_inverted_index.secondary | 30, 198 |
| abstract_inverted_index.suggested | 257 |
| abstract_inverted_index.survival, | 245 |
| abstract_inverted_index.typically | 15 |
| abstract_inverted_index.unrelated | 273 |
| abstract_inverted_index.additional | 44 |
| abstract_inverted_index.available. | 35 |
| abstract_inverted_index.co-primary | 28 |
| abstract_inverted_index.consistent | 175 |
| abstract_inverted_index.difference | 242 |
| abstract_inverted_index.elsewhere, | 52 |
| abstract_inverted_index.follow-up. | 127, 137, 158 |
| abstract_inverted_index.frequently | 2 |
| abstract_inverted_index.high-risk, | 92 |
| abstract_inverted_index.manuscript | 139 |
| abstract_inverted_index.reductions | 258 |
| abstract_inverted_index.demonstrate | 82, 119 |
| abstract_inverted_index.disseminate | 43 |
| abstract_inverted_index.noninferior | 87 |
| abstract_inverted_index.opportunity | 41 |
| abstract_inverted_index.recurrences | 261 |
| abstract_inverted_index.significant | 222 |
| abstract_inverted_index.disease-free | 163 |
| abstract_inverted_index.prespecified | 105 |
| abstract_inverted_index.anthracycline | 232, 264 |
| abstract_inverted_index.heterogeneity | 220 |
| abstract_inverted_index.Anthracyclines | 70 |
| abstract_inverted_index.noninferiority | 120, 181 |
| abstract_inverted_index.recurrence-free | 202 |
| abstract_inverted_index.nonanthracycline | 83, 123, 184 |
| abstract_inverted_index.anthracycline-based | 89, 215 |
| abstract_inverted_index.receptor–negative | 237 |
| cited_by_percentile_year.max | 100 |
| cited_by_percentile_year.min | 98 |
| countries_distinct_count | 2 |
| institutions_distinct_count | 21 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8500000238418579 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.97745212 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |